TABLE 1.
Gene array fold change, normal gravity vs. microgravity | Gene symbol | Gene title | Source |
---|---|---|---|
23.24 | EGR1 | Early growth response 1 | TarBase |
11.83 | EGR3 | Early growth response 3 | TargetScan |
5.86 | FASLG | Fas ligand (TNF superfamily, member 6) | TarBase + TargetScan |
5.33 | SPRY1 | Sprouty homolog 1, | TargetScan |
5.19 | BTG2 | BTG family, member 2 | TarBase + TargetScan |
4.63 | MYC | v-Myc myelocytomatosis viral oncogene homolog | TarBase |
4.32 | IRF4 | Interferon regulatory factor 4 | TarBase |
4.03 | SPRY2 | Sprouty homolog 2 | TarBase + TargetScan |
3.78 | TAGAP | T-cell Rho GTPase activating protein | TargetScan |
44.10 | CD40LG | T-cell activation GTPase TNF superfamily | No miR-21 seed sequence |
2.91 | CD83 | CD83 molecule | TarBase |
2.84 | REL | v-Rel | TarBase |
2.55 | NT5E (CD73) | 5′ Nucleotidase, ecto (CD73) | TarBase + TargetScan |
2.32 | CD69 | CD69 molecule | TargetScan |
Relative fold increases of gene expression from activated T cells in onboard normal gravity compared with those in microgravity were computed using gene array bioinformatics. Potential hsa-miR-21-5p target genes shown have differentially regulated between normal gravity and microgravity conditions. T cells from 3 independent donors were flown in space and activated with concanavalin A/anti-CD28 in microgravity or in normal gravity. Genes that had altered expression between microgravity and normal gravity were identified by 1-way ANOVA (≤0.05) with Benjamini-Hochberg multiple test correction and post hoc Tukey test. FASLG was not quite significant at P ≤ 0.05 but was significant at P ≤ 0.06 and thus is included in the list. Potential hsa-miRNA-21-5p targets were identified using TargetScan (predicted miRNA targets) and TarBase (confirmed miRNA–gene interactions).